| AKT | Protein-chinasi B |
| AMPK | Adenosine-monophosphate-activated protein kinase |
| AML | Acute promyelocytic leukemia |
| AP-1 | Activating protein-1 |
| APO-A1 | Apolipoprotein A1 |
| AR | Androgen receptor |
| ARH-I | Aplasia Ras homolog member I |
| ATF4 | Activating transcription factor 4 |
| BAD | BCL2-associated agonist of cell death |
| BAK | BCL-2 antagonist/killer |
| BAX | BCL-2-associated X protein |
| BCL-2 | B-cell lymphoma-2 |
| BCL-XL | B-cell lymphoma-extra large |
| BFL-1/A1 | Bcl-2-related protein A1 |
| BIM | BCL-2-interacting mediator of cell death |
| BIP | Immunoglobulin binding protein |
| BZM | Bortezomib |
| cAMP | Cyclic adenosine monophosphate |
| CD133 | Prominin-1 |
| CGE | Epigallocatechin |
| cGMP | Cyclic guanosine monophosphate |
| cIAP-2 | Cellular inhibitor of apoptosis 2 |
| COX | Cyclooxygenase |
| CSCs | Cancer stem cells |
| CUR | Curcumin |
| DR4 | Death receptor 4 |
| DR5 | Death receptor 5 |
| EGC | Epigallocatechin |
| EGCG | Epigallocatechin gallate |
| EGFR | Epidermal growth factor receptor |
| eIF2A | Eukaryotic translation initiation factor 2A |
| ER | Estrogen receptor |
| ERS | Endoplasmic reticulum stress |
| EZH2 | Enhancer of zeste homolog 2 |
| FADD | Fas-associated death domain |
| FAS | Fas cell surface death receptor |
| FASL | FAS ligand |
| FOXO1 | Forkhead box protein O1 |
| GA | Gallic acid |
| GRP78 | Glucose-regulated protein, 78 kDa |
| HER2 | Human epidermal growth factor receptor 2 |
| IAPs | Inhibitors of apoptosis proteins |
| IC50 | Half maximal inhibitory concentration |
| IGF-II | Insulin-like growth factor 2 |
| IGFR | Insulin-like growth factor receptor |
| IR | Insulin receptor |
| IRE1a | Inositol-requiring enzyme-1a |
| JAK | Janus kinase |
| JAK | Janus kinase |
| JNK | c-Jun N-terminal kinase |
| LDH | Lattate dehydrogenase |
| LGR5 | Leucine-rich repeat-containing G-protein-coupled receptor 5 |
| LKB1 | Live kinase B1 |
| lncRNAs | Long non-coding RNAs |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MAPKp38 | p38 mitogen-activated protein kinases |
| MCL1 | Myeloid cell leukemia-1 |
| MMP | Mitochondrial membrane potential |
| mTOR | Mammalian target of rapamycin |
| NAC | N-acetylcysteine |
| ncRNAs | Non-coding RNAs |
| NF-BkB | Nuclear factor kappa B |
| p27/KIP1 | Cyclin-dependent kinase inhibitor 1B |
| PARP-1 | Poly [ADP-ribose] polymerase 1 |
| PDCD4 | Molecule of programmed cell death 4 |
| PERK | Protein kinase RNA-like endoplasmic reticulum kinase |
| PI3K | Phoshatidylinositol-3 kinase |
| PIN1 | Peptidyl-prolyl isomerase NIMA-interacting 1 |
| PKA | Protein kinase A |
| PKB | Protein kinase B |
| PSA | Prostate specific antigen |
| PTEN | Phosphatase and tensin homolog |
| RASSF-1α | Ras association domain family 1 isoform A |
| ROS | Reactive oxygen species |
| RSV | Resveratrol |
| RTKs | Receptor tyrosine kinases |
| SHH | Sonic Hedgehog |
| SIRT1 | Sirtuin 1 |
| Sp1 | Specificity protein 1 |
| STAT1 | Signal transducer and activator of transcription 1 |
| STAT3 | Signal transducer and activator of transcription 3 |
| TNF | Tumor necrosis factor |
| TNF-α | Tumor necrosis factor α |
| TRAF2 | TNF receptor-associated factor 2 |
| VLDL | Very low-density lipoprotein |